Key result
Higher mean platelet volume was associated with a higher rate of cardiac death compared to lower mean platelet volume after PCI.
Why the study?
Does higher mean platelet volume predict cardiac death in patients after percutaneous coronary intervention?
Cohort (n=372)
Does higher mean platelet volume predict cardiac death in patients after percutaneous coronary intervention?
Mean platelet volume >8.20 fL is a predictive biomarker for cardiac death after PCI, with additive value in patients with myocardial injury or heart failure.
Answers are grounded in this paper and cite their sources.
Higher MPV may flag post-PCI patients for closer monitoring; leaves open incremental value over hs-cTnT/NT-proBNP in prospective validation.
The aim of this study was to determine the associations of the mean platelet volume (MPV) high-sensitivity cardiac troponin T (hs-cTnT) and N-terminal pro-B type natriuretic peptide (NT-proBNP) with the development of adverse outcomes after percutaneous coronary intervention (PCI). MPV hs-cTnT and NT-proBNP were analyzed in 372 patients who underwent PCI. The primary endpoint was cardiac death. The secondary endpoint analyzed was cardiovascular events (CVE): the composite of cardiac death, myocardial infarction (MI), target vessel revascularization (TVR), ischemic stroke and stent thrombosis (ST). The median MPV hs-cTnT and NT-proBNP levels were 8.20 (IQR 7.70-8.70) fL, 0.291 (IQR 0.015-3.785) ng/mL, and 105.25 (IQR 50.84-1128.5) pg/mL, respectively. There were 21 events of cardiac death, 10 MI (including 4 events of ST), 7 ischemic strokes and 29 TVR during a mean of 25.8 months of follow-up. The Kaplan-Meier analysis revealed that the higher MPV group (>8.20 fL, median) had a significantly higher cardiac death rate than the lower MPV group (≤8.20 fL; 9.4% vs. 2.1%, log-rank: p = 0.0026). When the MPV cut-off level was set to 8.20 fL using the receiver operating characteristic curve, the sensitivity was 81% and the specificity was 53.3% for differentiating between the group with cardiac death and the group without cardiac death. This value was more useful in patients with myocardial injury (hs-cTnT ≥ 0.1 ng/mL) or heart failure (NT-proBNP ≥ 450 pg/mL). The results of this study show that MPV is a predictive marker for cardiac death after PCI; its predictive power for cardiac death is more useful in patients with myocardial injury or heart failure.
No takes yet. Share an insight, caveat, or question.
Ki et al. (2013) conducted a cohort in Patients who underwent percutaneous coronary intervention (n=372). Higher mean platelet volume (>8.20 fL) vs. Lower mean platelet volume (≤8.20 fL) was evaluated on cardiac death (p=0.0026). Higher mean platelet volume was associated with a higher rate of cardiac death compared to lower mean platelet volume after PCI.
Synapse has enriched 10 related papers. Consider them for comparative context: